257 related articles for article (PubMed ID: 28746206)
1. Association between relative liver enhancement on gadoxetic acid enhanced magnetic resonance images and histologic grade of hepatocellular carcinoma.
Jin YJ; Cho SG; Lee KY; Kim JM; Lee JW
Medicine (Baltimore); 2017 Jul; 96(30):e7580. PubMed ID: 28746206
[TBL] [Abstract][Full Text] [Related]
2. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Jin YJ; Lee SH; Cho SG; Kim JH; Lee JW; Lee KY; Shin WY
J Gastroenterol Hepatol; 2016 Jul; 31(7):1349-56. PubMed ID: 26916616
[TBL] [Abstract][Full Text] [Related]
3. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
6. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
Medicine (Baltimore); 2017 Jul; 96(29):e7278. PubMed ID: 28723741
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
[TBL] [Abstract][Full Text] [Related]
8. Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images.
Chang WC; Chen RC; Chou CT; Lin CY; Yu CY; Liu CH; Chou JM; Hsu HH; Huang GS
Abdom Imaging; 2014 Dec; 39(6):1202-12. PubMed ID: 24869790
[TBL] [Abstract][Full Text] [Related]
9. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
10. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test.
Kim DK; Choi JI; Choi MH; Park MY; Lee YJ; Rha SE; Jung SE
AJR Am J Roentgenol; 2018 Sep; 211(3):580-587. PubMed ID: 29995498
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of gadoxetic acid-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma.
Tong HF; Liang HB; Mo ZK; Guan TP; Yang J; Fang CH
Clin Imaging; 2017; 43():9-14. PubMed ID: 28153667
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
15. Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma.
Peng Z; Jiang M; Cai H; Chan T; Dong Z; Luo Y; Li ZP; Feng ST
BMC Cancer; 2016 Aug; 16():625. PubMed ID: 27520833
[TBL] [Abstract][Full Text] [Related]
16. Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
Joo I; Kim SY; Kang TW; Kim YK; Park BJ; Lee YJ; Choi JI; Lee CH; Park HS; Lee K; Kim H; Yu E; Kang HJ; Ha SY; Kim JY; Ahn S; Jung ES; Kim BH; Han HS; Lee JM
Radiology; 2020 Aug; 296(2):335-345. PubMed ID: 32484414
[TBL] [Abstract][Full Text] [Related]
17. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.
Huang K; Dong Z; Cai H; Huang M; Peng Z; Xu L; Jia Y; Song C; Li ZP; Feng ST
BMC Cancer; 2019 Apr; 19(1):364. PubMed ID: 30999947
[TBL] [Abstract][Full Text] [Related]
18. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
[TBL] [Abstract][Full Text] [Related]
19. Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma.
Hwang JA; Kang TW; Kim YK; Kim SH; Paik YH; Ha SY; Kim S
Eur J Radiol; 2017 Oct; 95():362-369. PubMed ID: 28987693
[TBL] [Abstract][Full Text] [Related]
20. Peri-tumoral hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced MRI in hepatocellular carcinomas: correlation with peri-tumoral hyperplasia and its pathological features.
Yoneda N; Matsui O; Kitao A; Komori T; Kozaka K; Ikeda H; Yoshida K; Inoue D; Minami T; Koda W; Kobayashi S; Gabata T
Abdom Radiol (NY); 2018 Aug; 43(8):2103-2112. PubMed ID: 29260280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]